GC
Giuseppe Ciaramella
President

Giuseppe Ciaramella insider trades: Beam Therapeutics (BEAM) stock sales

President, Beam Therapeutics Last trade Apr 1, 2026 33 Form 4 filings
$1.4M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
15
Open-market trades
since 2020
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Giuseppe reports to the SEC

Open-market buys and sales

15 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 1, 2026BEAM↓ Sell$290K
Feb 24, 2026BEAM↓ Sell$1.1M
Apr 1, 2025BEAM↓ Sell$136K
Nov 6, 2024BEAM↓ Sell$1.3M
Oct 14, 2024BEAM↓ Sell$1.3M
Apr 1, 2024BEAM↓ Sell$146K
Jul 24, 2023BEAM↓ Sell$5.0M
Apr 4, 2023BEAM↓ Sell$109K
Jan 3, 2023BEAM↓ Sell$2.0M
Dec 12, 2022BEAM↓ Sell$2.2M
Mar 31, 2022BEAM↓ Sell$110K
Dec 22, 2021BEAM↓ Sell$225K
Dec 21, 2021BEAM↓ Sell$2.5M
Jun 28, 2021BEAM↓ Sell$8.4M
Dec 30, 2020BEAM↓ Sell$3.7M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BEAM insiders

Open-market trades in the last 12 months

About Giuseppe Ciaramella's insider trades

Giuseppe Ciaramella is President at Beam Therapeutics (BEAM). Since Dec 30, 2020, Giuseppe has reported no open-market purchases and 15 sales worth $28.6M on SEC Form 4. In the last 12 months: 2 sales ($1.4M).

Their filings also include option exercises (17 filings), grants and awards (12 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BEAM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.